Frank Haluska, SVP, Clinical R&D, CMO at ARIAD PHARMACEUTICALS INC (ARIA), sold 3,000 shares at $16.00 ($48K) on 2012-03-26, disclosed to the SEC on 2012-03-28.
Scheduled sale ($48k) by SVP, Clinical R&D, CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ARIA | SELL | 2016-02-03 | $155K | — | Filing → |
| ARIA | SELL | 2015-09-28 | $36K | — | Filing → |
| ARIA | SELL | 2015-07-16 | $38K | — | Filing → |